Urolithiasis in the COVID Era: An Opportunity to Reassess Management Strategies.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 32747201.
- Also identified by DOI 10.1016/j.eururo.2020.07.019 and PMC identifier 7832767.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Delayed evaluation and/or treatment for urolithiasis during the COVID-19 pandemic provide a unique opportunity to organically reassess many well-established stone management strategies. Nonopioid analgesia for renal colic and spontaneous passage trials appear to be two avenues worthy of investigation.
Medical subject headings
- COVID-19
- Referral and Consultation
- Renal Colic
- Urolithiasis
- Urology